Thomas Nusbickel - Feb 18, 2022 Form 4 Insider Report for CorMedix Inc. (CRMD)

Role
EVP, Chief Commercial Officer
Signature
/s/ Thomas Nusbickel
Stock symbol
CRMD
Transactions as of
Feb 18, 2022
Transactions value $
$0
Form type
4
Date filed
2/23/2022, 03:14 PM
Previous filing
May 20, 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CRMD Stock Option (Right to Buy Common Stock) Award $0 +100K $0.00 100K Feb 18, 2022 Common Stock 100K $4.03 Direct F1
holding CRMD Stock Option (Right to Buy Common Stock) 260K Feb 18, 2022 Common Stock 260K $7.56 Direct F2
holding CRMD Stock Option (Right to Buy Common Stock) 7.5K Feb 18, 2022 Common Stock 7.5K $7.56 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These options were granted on 02/18/2022. These options vest 1/4 on the date of grant, 1/4 on the first anniversary of the date of grant, 1/4 on the second anniversary of the date of grant and 1/4 on the third anniversary of the date of grant.
F2 The options vest as follows: 160,000 will vest over four years in four (4) equal installments on the first four anniversaries of May 13, 2021. The remaining 100,000 options vest on the achievement of certain milestones, subject to continued employment.
F3 These options were granted on May 13, 2021. These options shall vest in full on the first anniversary of the grant date, subject to continued employment.